Pfam Domains GO Terms
| Sulfatase |
| DUF3740 |
| esophagus smooth muscle contraction |
| N-acetylglucosamine-6-sulfatase activity |
| gastro-intestinal system smooth muscle contraction |
| glial cell-derived neurotrophic factor receptor signaling pathway |
| glomerular basement membrane development |
| glomerular filtration |
| renal filtration |
| arylsulfatase activity |
| regulation of hepatocyte proliferation |
| negative regulation of fibroblast growth factor receptor signaling pathway |
| glycosaminoglycan binding |
| innervation |
| positive regulation of vascular endothelial growth factor production |
| regulation of fibroblast growth factor receptor signaling pathway |
| liver regeneration |
| regulation of vascular endothelial growth factor production |
| heparan sulfate proteoglycan metabolic process |
| Golgi stack |
| chondrocyte development |
| glomerulus development |
| smooth muscle contraction |
| animal organ regeneration |
| nerve development |
| chondrocyte differentiation |
| proteoglycan metabolic process |
| renal system process |
| nephron development |
| liver development |
| embryonic skeletal system development |
| hepaticobiliary system development |
| positive regulation of canonical Wnt signaling pathway |
| negative regulation of cellular response to growth factor stimulus |
| regeneration |
| cartilage development |
| positive regulation of Wnt signaling pathway |
| bone development |
| connective tissue development |
| muscle contraction |
| regulation of animal organ morphogenesis |
| kidney development |
| regulation of cellular response to growth factor stimulus |
| regulation of canonical Wnt signaling pathway |
| renal system development |
| muscle system process |
| urogenital system development |
| regulation of epithelial cell proliferation |
| extracellular matrix organization |
| regulation of Wnt signaling pathway |
| extracellular structure organization |
| glycoprotein metabolic process |
| gland development |
| positive regulation of cytokine production |
| skeletal system development |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| response to wounding |
| cell surface |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| regulation of cytokine production |
| enzyme linked receptor protein signaling pathway |
| calcium ion binding |
| embryo development |
| endoplasmic reticulum |
| carbohydrate derivative metabolic process |
| regulation of anatomical structure morphogenesis |
| negative regulation of signal transduction |
| negative regulation of cell communication |
| negative regulation of signaling |
| extracellular space |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| cell development |
| positive regulation of signal transduction |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of cell communication |
| positive regulation of signaling |
| system process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Doxorubicin 0.02μM R08 exp478 | -1.79 |
| Ibrutinib 1μM R07 exp372 | -1.78 |
| Wortmannin 5μM R00 exp38 | 1.8 |
| Radicicol 0.16μM R05 exp242 | 1.9 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution